| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.445 | 0 | 4.098 | 6.367 | 6.133 | 7.173 | 6.956 | 9.099 | 10.079 | 11.417 |
| Total Income - EUR | 8.445 | 0 | 4.098 | 6.367 | 6.247 | 7.175 | 6.956 | 9.232 | 10.079 | 11.590 |
| Total Expenses - EUR | 4.761 | 697 | 1.115 | 3.595 | 5.943 | 6.607 | 5.589 | 5.438 | 3.282 | 5.437 |
| Gross Profit/Loss - EUR | 3.684 | -697 | 2.982 | 2.772 | 304 | 568 | 1.366 | 3.794 | 6.797 | 6.153 |
| Net Profit/Loss - EUR | 3.431 | -697 | 2.859 | 2.581 | 117 | 361 | 1.183 | 3.517 | 5.592 | 4.996 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Epicenter Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 43 | 0 | 0 | 13.178 | 9.214 | 5.400 | 1.721 | 0 | 0 | 0 |
| Current Assets | 2.545 | 1.864 | 4.966 | 7.734 | 4.805 | 7.356 | 11.147 | 13.596 | 13.196 | 9.851 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 61 | 60 | 605 | 336 | 0 | 467 | 2.523 | 4.912 | 3.763 | 3.721 |
| Cash | 2.484 | 1.804 | 4.360 | 7.398 | 4.805 | 6.889 | 8.624 | 8.684 | 9.434 | 6.130 |
| Shareholders Funds | 1.266 | 556 | 3.406 | 5.163 | 5.180 | 5.443 | 6.505 | 10.993 | 12.508 | 9.244 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.322 | 1.308 | 1.560 | 15.749 | 8.838 | 7.313 | 6.363 | 2.603 | 688 | 607 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Epicenter Med Srl